UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MDS-663 Improved Risk Stratification of MDS Patients With IPSS-M: A Single-Institution Experience

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S402-S402

2024

Volltextzugriff (PDF)

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I—Initial Work-up and Medical Management

The Journal of urology, 2021-10, Vol.206 (4), p.806-817

2021

Volltextzugriff (PDF)

COMPARISON OF PRE AND POST-TURP EVALUATION IN BPH PATIENTS USING IPSS AND UROFLOWMETRY IN TERTIARY HOSPITAL

Jurnal urologi Indonesia = Indonesian journal of Urology, 2024-09, Vol.31 (3)

2024

Volltextzugriff (PDF)

Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age

Blood reviews, 2023-05, Vol.59, p.101033-101033, Article 101033

2023

Volltextzugriff (PDF)

MDS-420 Low Risk Myelodysplastic Syndromes in Morocco

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S313

2022

Volltextzugriff (PDF)

Updates in Risk Stratification in Myelodysplastic Syndromes

The cancer journal (Sudbury, Mass.), 2023-05, Vol.29 (3), p.138-142

2023

Volltextzugriff (PDF)

Neueste Erkenntnisse zum myelodysplastischen Syndrom

Deutsche medizinische Wochenschrift, 2023-11, Vol.148 (22), p.1431-1436

2023

Volltextzugriff (PDF)

Neueste Erkenntnisse zum myelodysplastischen Syndrom

TumorDiagnostik & Therapie, 2024-03, Vol.45 (3), p.195-199

2024

Volltextzugriff (PDF)

MDS-370: Treatments and Outcomes for Patients with Myelodysplastic Syndromes (MDS) by Revised International Prognostic Scoring System (IPSS-R) Scores at the Huntsman Cancer Institute (HCI)

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S349-S349

2021

Volltextzugriff (PDF)

MDS-462 Response to Erythropoiesis-Stimulating Agent Therapy in IPSS-R Lower Risk Myelodysplastic Syndrome Patients Restratified According to IPSS-M

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S367-S368

2023

Volltextzugriff (PDF)

OUTCOMES ANALYSIS OF TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) AND TRANSURETHRAL VAPORIZATION OF THE PROSTATE (TUVP) IN PATIENT WITH BENIGN PROSTATE HYPERPLASIA: SYSTEMATIC REVIEW

Jurnal urologi Indonesia = Indonesian journal of Urology, 2023-05, Vol.30 (2)

2023

Volltextzugriff (PDF)

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023

The Journal of urology, 2024-01, Vol.211 (1), p.11-19

2024

Volltextzugriff (PDF)

MDS-529 The Prognostic Value of the Endothelial Activation and Stress Index (EASIX) Score, Platelet-to-Lymphocyte Ratio (PLR), and Neutrophil-to-Lymphocyte (NLR) in Myelodysplastic Syndrome Patients in Jordan after Adjusting for IPSS-R Risk Groups

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S321

2022

Volltextzugriff (PDF)

MDS-398 Incidence of Cytogenetic Abnormalities in Myelodysplastic Syndrome in the African American Population: A Decade-Long Single-Center Real-World Experience

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S395-S395

2024

Volltextzugriff (PDF)

Progress in Lower-Risk MDS

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S85-S86

Santini, Valeria

2024

Volltextzugriff (PDF)

MDS-531 Risk Stratification in Hypomethylating Agent-Treated Patients With Myelodysplastic Syndromes: A Multivariate Model

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S398-S398

2024

Volltextzugriff (PDF)

PREVALENCE OVERACTIVE BLADDER AT TERTIARY HOSPITAL : A RETROSPECTIVE SINGLE CENTER STUDY

Jurnal urologi Indonesia = Indonesian journal of Urology, 2022-09, Vol.29 (3)

2022

Volltextzugriff (PDF)

Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS‐M) prediction in myelodysplastic syndromes

Journal of internal medicine, 2024-07, Vol.296 (1), p.53-67

2024

Volltextzugriff (PDF)

The effect of bladder function on the efficacy of transurethral prostatectomy in patients with benign prostatic hyperplasia: a retrospective, single-center study

Asian journal of andrology, 2024-01, Vol.26 (1), p.112-118

2024

Volltextzugriff (PDF)

Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study

European journal of endocrinology, 2023-05, Vol.188 (5), p.448-456

2023

Volltextzugriff (PDF)

Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms

Hematology (Luxembourg), 2022-12, Vol.27 (1), p.1301-1304

2022

Volltextzugriff (PDF)

Therapeutic strategies in low and high-risk MDS: What does the future have to offer?

Blood reviews, 2021-01, Vol.45, p.100689-100689, Article 100689

2021

Volltextzugriff (PDF)

Prognostic scoring systems and risk stratification in myelodysplastic syndrome: focus on integration of molecular profile

Leukemia & lymphoma, 2022-06, Vol.63 (6), p.1281-1291

2022

Volltextzugriff (PDF)

Validation and Efficacy of the Modified International Prostate Symptom Score (IPSS) Thai Version: A Simplified Version for Assessing Lower Urinary Tract Symptoms in Thai Men

Journal of the Medical Association of Thailand, 2023-07, Vol.106 (7), p.715-721

2023

Volltextzugriff (PDF)

How can we incorporate molecular data into the IPSS?

Best practice & research. Clinical haematology, 2022-12, Vol.35 (4), p.101410-101410, Article 101410

Bejar, Rafael

2022

Volltextzugriff (PDF)

1 – 25 von 560

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(459)
Mit Volltextzugriff
(476)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

MDS-663 Improved Risk Stratification of MDS Patients With IPSS-M: A Single-Institution Experience

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I—Initial Work-up and Medical Management

COMPARISON OF PRE AND POST-TURP EVALUATION IN BPH PATIENTS USING IPSS AND UROFLOWMETRY IN TERTIARY HOSPITAL

Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age

MDS-420 Low Risk Myelodysplastic Syndromes in Morocco

Updates in Risk Stratification in Myelodysplastic Syndromes

Neueste Erkenntnisse zum myelodysplastischen Syndrom

Neueste Erkenntnisse zum myelodysplastischen Syndrom

MDS-370: Treatments and Outcomes for Patients with Myelodysplastic Syndromes (MDS) by Revised International Prognostic Scoring System (IPSS-R) Scores at the Huntsman Cancer Institute (HCI)

MDS-462 Response to Erythropoiesis-Stimulating Agent Therapy in IPSS-R Lower Risk Myelodysplastic Syndrome Patients Restratified According to IPSS-M

OUTCOMES ANALYSIS OF TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) AND TRANSURETHRAL VAPORIZATION OF THE PROSTATE (TUVP) IN PATIENT WITH BENIGN PROSTATE HYPERPLASIA: SYSTEMATIC REVIEW

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023

MDS-529 The Prognostic Value of the Endothelial Activation and Stress Index (EASIX) Score, Platelet-to-Lymphocyte Ratio (PLR), and Neutrophil-to-Lymphocyte (NLR) in Myelodysplastic Syndrome Patients in Jordan after Adjusting for IPSS-R Risk Groups

MDS-398 Incidence of Cytogenetic Abnormalities in Myelodysplastic Syndrome in the African American Population: A Decade-Long Single-Center Real-World Experience

Progress in Lower-Risk MDS

MDS-531 Risk Stratification in Hypomethylating Agent-Treated Patients With Myelodysplastic Syndromes: A Multivariate Model

PREVALENCE OVERACTIVE BLADDER AT TERTIARY HOSPITAL : A RETROSPECTIVE SINGLE CENTER STUDY

Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS‐M) prediction in myelodysplastic syndromes

The effect of bladder function on the efficacy of transurethral prostatectomy in patients with benign prostatic hyperplasia: a retrospective, single-center study

Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study

Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms

Therapeutic strategies in low and high-risk MDS: What does the future have to offer?

Prognostic scoring systems and risk stratification in myelodysplastic syndrome: focus on integration of molecular profile

Validation and Efficacy of the Modified International Prostate Symptom Score (IPSS) Thai Version: A Simplified Version for Assessing Lower Urinary Tract Symptoms in Thai Men

How can we incorporate molecular data into the IPSS?

Suchergebnisse filtern